Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Current Assets: 2024-2025

Historic Current Assets for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $83.1 million.

  • Pyxis Oncology's Current Assets fell 44.20% to $83.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.1 million, marking a year-over-year decrease of 44.20%. This contributed to the annual value of $132.4 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Pyxis Oncology's Current Assets stood at $83.1 million, which was down 16.89% from $100.0 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Current Assets registered a high of $172.4 million during Q1 2024, and its lowest value of $83.1 million during Q3 2025.
  • For the 2-year period, Pyxis Oncology's Current Assets averaged around $129.9 million, with its median value being $132.4 million (2024).
  • Data for Pyxis Oncology's Current Assets shows a maximum YoY plummeted of 44.20% (in 2025) over the last 5 years.
  • Pyxis Oncology's Current Assets (Quarterly) stood at $132.4 million in 2024, then crashed by 44.20% to $83.1 million in 2025.
  • Its Current Assets was $83.1 million in Q3 2025, compared to $100.0 million in Q2 2025 and $111.9 million in Q1 2025.